<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >Hypertension or 'high blood pressure' carries an increased risk of early death from stroke, heart attack, heart failure and kidney failure if it is not detected early and properly controlled. Owing to this, the focus must be on when to initiate treatment, rather than how hypertension should be defined.</span></p><p style="text-align:justify;"><span >Since there are often no specific symptoms associated with hypertension, there is the need for regular blood pressure (BP) screening in the adult population for early detection.</span></p><p style="text-align:justify;"><span >In the general adult population, treatment must be initiated at a  BP of 140/90 mmHg or higher for individuals below 60 years of age, and 150/90 mmHg or higher in those above 60 years. For individuals with diabetes mellitus or non-diabetics with Chronic Kidney Disease (CKD), treatment for hypertension must be initiated at a BP of 140/90 mmHg, irrespective of age.</span></p><p style="text-align:justify;"><span >In the majority of patients with hypertension, no specific underlying cause is identified (primary hypertension). In these individuals, increasing age, family history, excess body weight, lack of physical activity and excessive alcohol intake may be possible predisposing factors. In about 10% of cases of hypertension, there may be an underlying kidney disease, endocrine disorder, renal artery stenosis or coarctation of the aorta (secondary hypertension).</span></p><p style="text-align:justify;"><span >Once a diagnosis of hypertension is made, the individual should     be evaluated to exclude secondary causes and to identify other existing cardiovascular risk factors e.g. diabetes, dyslipidaemia, hyperuricaemia, etc.</span></p><p style="text-align:justify;"> </p><h3>CAUSES</h3><p> • Primary hypertension</p><p> • Secondary hypertension</p><p>•  Kidney related-CKD, polycystic kidney disease</p><p>•  Endocrine - phaeochromocytoma, Cushing's syndrome, Conn's syndrome, hypothyroidism, hyperthyroidism, acromegaly</p><p>•     Vascular - renal artery stenosis, coarctation of the aorta</p><h3>SYMPTOMS</h3><p> • Usually none</p><p> • Occasionally,</p><p>•  Headaches</p><p>•  Palpitations</p><p>•  Dizziness</p><p>•  Easy fatiguability</p><h3>SIGNS</h3><p> • Blood pressure 2" 140/90 mmHg</p><p> • Displaced apex beat</p><p> • Signs pointing to a specific cause for secondary hypertension</p><h3>INVESTIGATIONS</h3><p> • FBC</p><p> • Urinalysis</p><p> • Blood urea, electrolytes and creatinine</p><p> • Blood glucose</p><p> • Serum lipids</p><p> • Serum uric acid</p><p> • Chest X-ray</p><p> • 12-lead ECG</p><p> • Ultrasound scan of kidneys and adrenals (in suspected secondary hypertension)</p><p> • Echocardiogram</p><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><p> • To reduce blood pressure levels to recommended targets:</p><p>•  &lt; 140/90mmHg for age below 60 years, diabetes, CKD</p><p>•  &lt; 150/90 mmHg for age above 60 years</p><p> • To manage co-morbid conditions e.g. obesity, diabetes, lipids etc.</p><p> • To prevent cardiovascular, cerebrovascular and renal complications</p><p> • To promote therapeutic lifestyle changes e.g. smoking cessation, regular physical activity, reduction in alchohol intake</p><p> • To identify and manage secondary hypertension appropriately</p><h3>Non-pharmacological treatment</h3><p> • Reduce salt intake</p><p> • Reduce animal fat intake</p><p> • Ensure regular fruit and vegetable intake</p><p> • Weight reduction in obese and overweight individuals</p><p> • Regular exercise e.g. brisk walking for 30 minutes 3 times a week</p><p> • Reduction in alcohol consumption</p><p> • Avoid or quit smoking</p><p> </p><h3>Pharmacological treatment</h3><p><span ><strong>A. Treatment of hypertension </strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><p><span ><strong> Evidence Rating: [A]</strong></span></p><h3>Thiazide Diuretics:</h3><p> • Bendroflumethiazide, oral, 2.5 mg daily</p><h3>Or</h3><p> • Hydrochlorothiazide, oral, 12.5 mg-25 mg daily</p><h3>And/Or</h3><h3>Calcium Channel Blockers:</h3><ul><li>Amlodipine, oral, 5-10 mg daily</li></ul><h3>Or</h3><p> • Nifedipine retard, oral, 10-40 mg 12 hourly</p><h3>And/Or</h3><p><strong>Angiotensin-converting enzyme (ACE) inhibitors</strong></p><p> • Lisinopril, oral, 5-40 mg daily</p><h3>Or</h3><p> • Ramipril, oral, 2.5-10 mg daily</p><h3>Or</h3><h3><strong>Angiotensin receptor blockers</strong></h3><ul><li>Losartan, oral, 25-100 mg daily</li></ul><h3>Or</h3><p>     • Candesartan, oral, 4-32 mg daily</p><h3>Or</h3><ul><li>Valsartan, oral, 80-160 mg daily</li></ul><h3>And/Or</h3><p><strong>Beta-blockers:</strong></p><p> • Atenolol, oral, 50 -100 mg daily</p><h3>Or</h3><p> • Bisoprolol, oral, 5-20 mg daily</p><h3>Or</h3><p> • Metoprolol, oral, 50-200 mg 12 hourly</p><h3>Or</h3><ul><li>Carvedilol, oral, 12.5-50 mg daily</li></ul><h3>Or</h3><p> • Labetalol, oral, 100-400 mg 12 hourly</p><p><span ><strong>2<sup>nd</sup> Line Treatment </strong></span></p><p><span ><strong>Evidence Rating: [C] </strong></span></p><p><strong>Centrally acting agents</strong></p><p> • Methyldopa, oral, 250 mg-1g 8-12 hourly</p><h3>And/Or</h3><p><strong>Vasodilators</strong></p><p> • Hydralazine, oral, 25-50 mg 12 hourly</p><h3>And/Or</h3><p><strong>Alpha-blockers</strong></p><p> • Prazosin, oral, 0.5 mg 8-12hourly and increasing gradually to a max. dose of 20 mg</p><h3>And/Or</h3><p><strong>Aldosterone antagonists</strong></p><p>• Spironolactone, oral, 25-50 mg daily</p><p> </p><h3>REFERRAL CRITERIA</h3><p><span >Refer the following categories of hypertensive patients to an</span></p><p><span >appropriate specialist:</span></p><p> • Those not achieving the target blood pressure (BP) level after several months of treatment</p><p> • Those on three or more anti-hypertensive drugs, yet have poor BP</p><p>control</p><p> • Those with worsening of BP over a few weeks or months</p><p> • Those with plasma creatinine levels above the upper limit of normal</p><p> • Those with diabetes mellitus</p><p> • Those with multiple risk factors (diabetes, dyslipidaemia, obesity, family history of heart disease)</p><p> • Those not on diuretics but have persistently low potassium on</p><p>repeated blood tests</p><p> • All children, young adults and pregnant women with elevated BP</p>
    <p><strong> FLOWCHART</strong></p>
    <div style="width: 95vw;">
    <img src="https://osamfrimpong.github.io/stg_app_web/images/hypertension.png" alt="Flowchart: Hypertension" style="max-width: 100%;height: auto;margin: auto;">
    </div>
    <p><br /><strong>Fig 7-8: Flowchart: Hypertension</strong></p>
</body>
</html>
